Results : Of 133 patients, 106 achieved treatment stability on Avastin 70 patients were stable on injections every 8 weeks or longer, and 36
Avastin is the brand name for the anti-cancer medication bevacizumab, which belongs to a group of drugs called monoclonal antibodies In 1997, clinical trials of Avastin began The main trial upon which FDA approval was based was a Phase III trial involving 813 patients The
77 bet Key Words: Epistaxis, hereditary hemorrhagic telangiectasia, Osler Weber Rendu, Bevacizumab, Avastin Level of Evidence: 2b Laryngoscope, 121:644–646, 2011 Avastin is a drug used to treat wet age-related macular degeneration It is also used to treat diabetic eye disease and other problems